在美国遵守抗结核药物治疗方案:来自MarketScan数据库的见解,2016-2022年
Pooja Gokhale1, Lorenzo Villa Zapata1
1Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, Athens, GA, USA.
概括
在美国,对一线结核病药物的坚持是不理想的. 与异化和利法相比,乙醇和皮拉津胺显示出更高的患者坚持治疗.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 药物经济学 药物经济学
背景情况:
- 结核病 (TB) 是一个重大的全球卫生挑战.
- 坚持抗结核治疗对于预防结核病传播和耐药性至关重要.
- 评估对第一线结核病药物的坚持对于有效的治疗策略至关重要.
研究的目的:
- 评估患者对美国一线抗结核药物的坚持.
- 为了确定不同一线结核病药物之间坚持率的变化.
主要方法:
- 使用Merative MarketScan商业和医疗补助索赔数据 (2016-2022) 的回顾性队列研究.
- 纳入标准:患有对异化,利法,乙胺醇和皮拉津胺胺的要求的患者.
- 坚持度高,定义为在6个月的随访期内覆盖的日数≥80%的比例.
主要成果:
- 该研究包括168名医疗补助和257名商业保险患者.
- 对于异化 (45.8%-50.2%) 和利法 (56.6%在医疗补助中) 观察到的最低的坚持.
- 对于乙醇 (68.9%-71.4%) 和金胺 (67.3%-71.6%) 观察到更高的坚持率.
结论:
- 在美国,对一线抗结核药物的坚持仍然不理想.
- 与异化和利法相比,乙醇和皮拉津胺的坚持率更高.
- 研究结果可能表明,结核病治疗的密集阶段,结核病治疗的坚持更好.
相关概念视频
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...


